Montreal-based BCA Research, an independent institutional research provider, has expanded its Equity Trading Strategy (ETS) offering, which provides investors with actionable research and analytics, to cover equity markets listed in the MSCI World Index.
The new service combines BCA’s proprietary macroeconomic framework with industry expertise and quantitative modeling to deliver a 360-degree view of a company from an investment perspective. The service provides unique insights and actionable investment opportunities that are based on the key drivers of share price performance.
ETS is led by BCA’s Chief Global Strategist Peter Berezin, a longtime veteran of the financial markets, and it filters over 20 proven factors that contribute to strong performances into a single metric – the BCA Score, which ranks and scores over 10,000 equities in terms of performance potential.
ADALend: New Wave of DeFi Loans on CardanoGo to article >>
The product is the next step in BCA’s independent research offering which deploys a hybrid model in which research provides big-data scalability as well as researchers providing expert interpretation.
Founded in 1949 and headquartered in Montreal, BCA Research is an independent provider of global investment research. The firm focuses its research on equities, currencies, commodities, and fixed income. It offers research across the globe including United States, Europe, and China.
Bashar AL-Rehany, CEO of BCA Research, commented: “Since the initial launch of ETS, our clients have demanded that we expand our model to include global equity markets. We have listened and are pleased to announce the expansion of the service to cover all developed markets.”
“We have seen a strong demand from the global investment management community for hybrid research offerings, which combine BCA’s proven expertise in research and analysis with big data algorithms and analytics. ETS, as well as our research platform Edge, answer that demand by helping investors better understand markets, and make better investment decisions,” he added.